标题
Vaccine third dose and cancer patients: necessity or luxury?
作者
关键词
-
出版物
ESMO Open
Volume 6, Issue 6, Pages 100306
出版商
Elsevier BV
发表日期
2021-11-11
DOI
10.1016/j.esmoop.2021.100306
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Rich countries should tithe their vaccines
- (2021) Gavin Yamey NATURE
- Impaired immunogenicity of BNT162b2 anti-SARS-CoV-2 vaccine in patients treated for solid tumors
- (2021) J. Barrière et al. ANNALS OF ONCOLOGY
- 1557O Adaptive immunity to SARS-CoV-2 infection and vaccination in cancer patients: The CAPTURE study
- (2021) S.T.C. Shepherd et al. ANNALS OF ONCOLOGY
- Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer
- (2021) Alfredo Addeo et al. CANCER CELL
- Seroconversion rates following COVID-19 vaccination among patients with cancer
- (2021) Astha Thakkar et al. CANCER CELL
- Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer
- (2021) Sidse Ehmsen et al. CANCER CELL
- Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer
- (2021) Mario Mairhofer et al. CANCER CELL
- The devil in the details: Herd immunity and pandemic response
- (2021) Beau Schaeffer et al. Cell Host & Microbe
- Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
- (2021) Victoria G. Hall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccine nationalism and the dynamics and control of SARS-CoV-2
- (2021) Caroline E. Wagner et al. SCIENCE
- How the world is (not) handling surplus doses and expiring vaccines
- (2021) Jane Feinmann BMJ-British Medical Journal
- Profiteering from vaccine inequity: a crime against humanity?
- (2021) Fatima Hassan et al. BMJ-British Medical Journal
- Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020–August 2021
- (2021) Ashley Fowlkes et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021
- (2021) Mark W. Tenforde et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021
- (2021) Catherine M. Brown et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer
- (2021) Amir Massarweh et al. JAMA Oncology
- Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer
- (2021) Tal Goshen-Lago et al. JAMA Oncology
- Responses to SARS-CoV-2 Vaccination in Patients with Cancer (ReCOVer Study): A Prospective Cohort Study of the Hellenic Cooperative Oncology Group
- (2021) Helena Linardou et al. Cancers
- High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated with chemotherapy for solid cancers
- (2021) R. Palich et al. ANNALS OF ONCOLOGY
- SARS-CoV-2 mutational cascades and the risk of hyper-exponential growth
- (2021) John M. Halley et al. MICROBIAL PATHOGENESIS
- Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors
- (2021) Rachna T. Shroff et al. NATURE MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started